
International Journal of Chemical Kinetics p. 483 - 488 (2005)
Update date:2022-08-15
Topics:
Selvararani
Medona
Ramachandran
The kinetics of ketone-catalyzed decomposition of caroate (peroxomonosulfate) was studied in aqueous alkaline medium at 25°C. The rate follows simple second-order kinetics, first order in each (Ketone) and [PMS]. The rate constant values are independent of hydroxide ion concentrations over the range from 0.05 M to 0.15 M. The experimental results suggest that the nucleophilic addition of SO5-2 ion at the carbonyl carbon leads to the formation of oxirane intermediate in the rate-determining step. Oxirane reacts rapidly with another SO52- to give the parent ketone, oxygen, and SO42-. The observed substituent effect on the activation energy EA and Arrhenius (A) factor suggests that the electron-donating substituents stabilize the activated state and make the entropy of activation more negative. This can be explained by the fact that the mechanism of oxirane formation shifts from concentric to nonconcentric process as we go from acetone to 3-hexanone.
View More
Liaoyang Xinyou Chemical Products Co.,Ltd.
Contact:+86-419-5165433 13604191870
Address:Huishang Road6-1, Hongwei District, Liaoyang, Liaoning, China
SuZhou Hua-Emy Chemical Import and Export Co., LTD.
Contact:+86-512-88804994; +86-512-88804550;
Address:710, Building B, International Trade Center, 12 Huanghelu, Changshu, Jiangsu,China
Contact:86-21 60347964
Address:No.1304, West Meilong Road, Minhang District, Shanghai, China
SHAANXI FUJIE PHARMACEUTICAL CO.,LTD
website:http://www.fujiepharm.com
Contact:+86-29-63650906
Address:Yuanqu Yi Road, Qinghe Food Industrial Park, Sanyuan County, Shaanxi Province, China
Weifang Jahwa Chemical Co.,Ltd
Contact:0086-536-8897731,8897730
Address:No.5166 East Dongfeng Street,Weifang,Shandong,China
Doi:10.1016/j.molstruc.2017.03.082
(2017)Doi:10.1021/ja0256010
(2002)Doi:10.1023/B:RJAC.0000008318.22178.07
(2003)Doi:10.1016/j.jorganchem.2009.08.032
(2009)Doi:10.1016/j.ejmech.2017.01.040
(2017)Doi:10.1016/j.farmac.2003.07.011
(2004)